MicroRNAs as participants in cytotoxicity of CdTe quantum dots in NIH/3T3 cells

Biomaterials

Volumn 32, Issue 15, 2011, Pages 3807-3814

  Li, Shuchun ^a   Wang, Yong ^a   Wang, Haitao ^a   Bai, Yunfei ^a   Liang, Gaofeng ^a   Wang, Yuanyuan ^a   Huang, Ningping ^a   Xiao, Zhongdang ^a  

^a SOUTHEAST UNIVERSITY   (China)

Author keywords

CdTe QDs; Cytotoxicity; MicroRNA; MiRNA biogenesis; P53

Indexed keywords

ADAPTIVE PROCESS; APOPTOSIS; CDTE; CDTE QUANTUM DOTS; CELL SURVIVAL; DIFFERENTIAL EXPRESSIONS; DOSE-DEPENDENT; EPIGENETIC MECHANISMS; EXPRESSION LEVELS; EXPRESSION PATTERNS; EXTERNAL STIMULUS; MICRORNA; MICRORNA (MIRNA); MICRORNAS; MIRNA BIOGENESIS; MRNA LEVEL; P53; P53 PROTEIN; POST-TRANSLATIONAL MODIFICATIONS;

CADMIUM ALLOYS; CADMIUM COMPOUNDS; CELL DEATH; CYTOTOXICITY; GENES; PHOSPHORYLATION; TRANSCRIPTION;

SEMICONDUCTOR QUANTUM DOTS;

CADMIUM DERIVATIVE; CADMIUM TELLURIDE; MESSENGER RNA; MICRORNA; PROTEIN P53; QUANTUM DOT; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BIOGENESIS; CELL STRAIN 3T3; CELL STRUCTURE; CELL SURVIVAL; CYTOTOXICITY; DOWN REGULATION; EPIGENETICS; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENOTOXICITY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; UPREGULATION;

ANIMALS; CADMIUM COMPOUNDS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; MICE; MICRORNAS; MUTAGENS; NIH 3T3 CELLS; PROTEIN PROCESSING, POST-TRANSLATIONAL; QUANTUM DOTS; TELLURIUM; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79952757232     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.01.074     Document Type: Article

References (47)

1. RiveraGil P., Oberdorster G., Elder A., Puntes V., Parak W.J. Correlating physico-chemical with toxicological properties of nanoparticles: the present and the future. ACS Nano 2010, 4:5527-5531.
2. Weiss P.S. The big picture. ACS Nano 2009, 3:1603-1604.
3. Cho S.J., Maysinger D., Jain M., Roder B., Hackbarth S., Winnik F.M. Long-term exposure to CdTe quantum dots causes functional impairments in live cells. Langmuir 2007, 23:1974-1980.
4. Zhang Y., Mi L., Xiong R., Wang P.N., Chen J.Y., Yang W., et al. Subcellular localization of thiol-capped CdTe quantum dots in living cells. Nanoscale Res Lett 2009, 4:606-612.
5. Su Y., Hu M., Fan C., He Y., Li Q., Li W., et al. The cytotoxicity of CdTe quantum dots and the relative contributions from released cadmium ions and nanoparticle properties. Biomaterials 2010, 31:4829-4834.
6. Prasad B.R., Nikolskaya N., Connolly D., Smith T.J., Byrne S.J., Gerard V.A., et al. Long-term exposure of CdTe quantum dots on PC12 cellular activity and the determination of optimum non-toxic concentrations for biological use. J Nanobiotechnology 2010, 8:7.
7. Lovric J., Cho S.J., Winnik F.M., Maysinger D. Unmodified cadmium telluride quantum dots induce reactive oxygen species formation leading to multiple organelle damage and cell death. Chem Biol 2005, 12:1227-1234.
8. Conroy J., Byrne S.J., Gun'ko Y.K., Rakovich Y.P., Donegan J.F., Davies A., et al. CdTe nanoparticles display tropism to core histones and histone-rich cell organelles. Small 2008, 4:2006-2015.
9. Choi A.O., Brown S.E., Szyf M., Maysinger D. Quantum dot-induced epigenetic and genotoxic changes in human breast cancer cells. J Mol Med 2008, 86:291-302.
10. Singh N., Manshian B., Jenkins G.J., Griffiths S.M., Williams P.M., Maffeis T.G., et al. NanoGenotoxicology: the DNA damaging potential of engineered nanomaterials. Biomaterials 2009, 30:3891-3914.
11. Myllynen P. Nanotoxicology: damaging DNA from a distance. Nat Nanotechnol 2009, 4:795-796.
12. Petersen E.J., Nelson B.C. Mechanisms and measurements of nanomaterial induced oxidative damage to DNA. Anal Bioanal Chem 2010, 398:613-650.
13. Maysinger D. Nanoparticles and cells: good companions and doomed partnerships. Org Biomol Chem 2007, 5:2335-2342.
14. Iorio M.V., Piovan C., Croce C.M. Interplay between microRNAs and the epigenetic machinery: an intricate network. Biochim Biophys Acta 2010, 1799:694-701.
15. Suzuki H.I., Yamagata K., Sugimoto K., Iwamoto T., Kato S., Miyazono K. Modulation of microRNA processing by p53. Nature 2009, 460:529-533.
16. Xing B., Li W.W., Sun K. A novel synthesis of high quality CdTe quantum dots with good thermal stability. Mater Lett 2008, 62:3178-3180.
17. Wang Y., Zheng J.W., Zhang Z.J., Yuan C.W., Fu D.G. CdTe nanocrystals as luminescent probes for detecting ATP, folic acid and L-cysteine in aqueous solution. Colloid Surf A 2009, 342:102-106.
18. Kal A.J., van Zonneveld A.J., Benes V., van den Berg M., Koerkamp M.G., Albermann K., et al. Dynamics of gene expression revealed by comparison of serial analysis of gene expression transcript profiles from yeast grown on two different carbon sources. Mol Biol Cell 1999, 10:1859-1872.
19. Ruijter J.M., Van Kampen A.H., Baas F. Statistical evaluation of SAGE libraries: consequences for experimental design. Physiol Genomics 2002, 11:37-44.
20. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT Method. Methods 2001, 25:402-408.
21. Ngamwongsatit P., Banada P.P., Panbangred W., Bhunia A.K. WST-1-based cell cytotoxicity assay as a substitute for MTT-based assay for rapid detection of toxigenic Bacillus species using CHO cell line. J Microbiol Methods 2008, 73:211-215.
22. Samia A.C., Chen X., Burda C. Semiconductor quantum dots for photodynamic therapy. J Am Chem Soc 2003, 125:15736-15737.
23. Su Y.Y., He Y., Lu H.T., Sai L.M., Li Q.N., Li W.X., et al. The cytotoxicity of cadmium based, aqueous phase - synthesized, quantum dots and its modulation by surface coating. Biomaterials 2009, 30:19-25.
24. Jan E., Byrne S.J., Cuddihy M., Davies A.M., Volkov Y., Gun'ko Y.K., et al. High-content screening as a universal tool for fingerprinting of cytotoxicity of nanoparticles. ACS Nano 2008, 2:928-938.
25. Qi Y., Tu J., Cui L., Guo X., Shi Z., Li S., et al. High-throughput sequencing of microRNAs in adenovirus type 3 infected human laryngeal epithelial cells. J Biomed Biotechnol 2010, 2010:915980.
26. Schulte J.H., Marschall T., Martin M., Rosenstiel P., Mestdagh P., Schlierf S., et al. Deep sequencing reveals differential expression of microRNAs in favorable versus unfavorable neuroblastoma. Nucleic Acids Res 2010, 38:5919-5928.
27. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
28. Ambros V. The functions of animal microRNAs. Nature 2004, 431:350-355.
29. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., et al. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838.
30. Hermeking H. p53 enters the microRNA world. Cancer Cell 2007, 12:414-418.
31. Ji Q., Hao X., Meng Y., Zhang M., Desano J., Fan D., et al. Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres. BMC Cancer 2008, 8:266.
32. Zhang Y., Chen W., Zhang J., Liu J., Chen G., Pope C. In vitro and in vivo toxicity of CdTe nanoparticles. J Nanosci Nanotechnol 2007, 7:497-503.
33. Cai X., Hagedorn C.H., Cullen B.R. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 2004, 10:1957-1966.
34. Lee Y., Kim M., Han J., Yeom K.H., Lee S., Baek S.H., et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J 2004, 23:4051-4060.
35. Kim V.N., Han J., Siomi M.C. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 2009, 10:126-139.
36. Chuang J.C., Jones P.A. Epigenetics and microRNAs. Pediatr Res 2007, 61:24R-29R.
37. Agirre X., Vilas-Zornoza A., Jimenez-Velasco A., Martin-Subero J.I., Cordeu L., Garate L., et al. Epigenetic silencing of the tumor suppressor microRNA hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia. Cancer Res 2009, 69:4443-4453.
38. Bueno M.J., Perez de Castro I., Gomez de Cedron M., Santos J., Calin G.A., Cigudosa J.C., et al. Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell 2008, 13:496-506.
39. Toyota M., Suzuki H., Sasaki Y., Maruyama R., Imai K., Shinomura Y., et al. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res 2008, 68:4123-4132.
40. Levine A.J. The p53 tumor-suppressor gene. N Engl J Med 1992, 326:1350-1352.
41. Meek D.W. Post-translational modification of p53. Semin Cancer Biol 1994, 5:203-210.
42. Ashcroft M., Kubbutat M.H., Vousden K.H. Regulation of p53 function and stability by phosphorylation. Mol Cell Biol 1999, 19:1751-1758.
43. Chang T.C., Wentzel E.A., Kent O.A., Ramachandran K., Mullendore M., Lee K.H., et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 2007, 26:745-752.
44. Corney D.C., Flesken-Nikitin A., Godwin A.K., Wang W., Nikitin A.Y. microRNA-34b and microRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res 2007, 67:8433-8438.
45. He L., He X., Lim L.P., de Stanchina E., Xuan Z., Liang Y., et al. A microRNA component of the p53 tumour suppressor network. Nature 2007, 447:1130-1134.
46. Zeng Y. Principles of microRNA production and maturation. Oncogene 2006, 25:6156-6162.
47. Wang X., Li Y., Xu X., Wang Y.H. Toward a system-level understanding of microRNA pathway via mathematical modeling. Biosystems 2010, 100:31-38.